In US patients with CKD and type 2 diabetes receiving routine care, SGLT2i use was associated with higher risks of genital infections and potentially lower limb amputations and nonvertebral fractures.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: